chitosan has been researched along with risperidone in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kumar, M; Misra, A; Pathak, K | 1 |
| He, HB; Lin, X; Tang, X; Xu, YH; Zhang, Y | 1 |
| Ahad, A; Aqil, M; Imam, SS; Qureshi, M; Sultana, Y | 1 |
3 other study(ies) available for chitosan and risperidone
| Article | Year |
|---|---|
Formulation and characterization of nanoemulsion-based drug delivery system of risperidone.
Topics: Administration, Intranasal; Animals; Antipsychotic Agents; Blood-Brain Barrier; Chitosan; Diffusion; Drug Compounding; Drug Delivery Systems; Drug Stability; Emulsions; In Vitro Techniques; Nanoparticles; Nasal Mucosa; Rats; Risperidone; Sheep; Solubility; Tissue Distribution | 2009 |
[Preparation and evaluation of risperidone-loaded microsphere/sucrose acetate isobutyrate in situ forming complex depot with double diffusion barriers].
Topics: Chitosan; Drug Carriers; Lactic Acid; Microspheres; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Risperidone; Sucrose; Technology, Pharmaceutical | 2015 |
Formulation and Evaluation of Neuroactive Drug Loaded Chitosan Nanoparticle for Nose to Brain Delivery: In-vitro Characterization and In-vivo Behavior Study.
Topics: Administration, Intranasal; Animals; Antipsychotic Agents; Behavior, Animal; Brain; Catalepsy; Chitosan; Drug Carriers; Drug Compounding; Drug Liberation; Locomotion; Nanoparticles; Nasal Mucosa; Rats; Risperidone; Swine | 2019 |